13 octobre 2024
Linkedin Twitter

FDA previews safety-focused STeP pathway, finalizes breakthrough device guidance

FDA Revises 1989 Guidance on Drug Master Files

Roche, Novo Nordisk and Merck Weigh in on FDA Draft Guidance on Assessment of Pressor Effects
drapeau_union_europenne-1
RIS.WORLD
RIS.WORLD est le Magazine Réglementaire des Industries de Santé
Contactez-nous: contact@ris.world
Linkedin Twitter
© 2023 - RIS.WORLD By WHITE-TILLET